As Nifty struggles, defensive FMCG and pharma deliver returns of up to 23% in a month

As Nifty struggles, defensive FMCG and pharma deliver returns of up to 23% in a month

FMCG and pharma stocks have rallied by up to 23% over the last month, demonstrating their reputation as defensive bets. In contrast, the Nifty50 index has slipped into the red amid high volatility, with the India VIX rising over 27% during the same period. At the index level, Nifty FMCG and Nifty Pharma have returned … Read more

hul shares: Stocks in news: HUL, Bajaj Finance, Suzlon Energy, Federal Bank, Gensol Engineering

hul shares: Stocks in news: HUL, Bajaj Finance, Suzlon Energy, Federal Bank, Gensol Engineering

Domestic markets closed lower on Monday due to selling in index heavyweight Reliance Industries and Kotak Bank on muted earnings and caution ahead of the Union Budget. In today’s trade, shares of HUL, Bajaj Finance, Suzlon Energy, Federal Bank, Gensol Engineering among others will be in focus due to various developments and quarterly earnings HUL, … Read more

hul shares: Big movers on D-Street: What should investors do with HUL, IRCTC and RVNL?

hul shares: Big movers on D-Street: What should investors do with HUL, IRCTC and RVNL?

Rebounding from their worst single-day slide in four years, benchmark indices Sensex and Nifty soared over 3% each on heavy value buying by investors after NDA alliance partners started talks on government formation. The stocks that were in focus included names like HUL, which rose 4.29%; IRCTC, which gained 0.6%; and RVNL, whose shares rose … Read more

HUL shares fall over 3% after Q3 earnings. Should you buy, sell or hold?

HUL shares fall over 3% after Q3 earnings. Should you buy, sell or hold?

Shares of Hindustan Unilever (HUL) fell over 3% to the day’s low of Rs 2,487 on Saturday following its December quarter earnings where the fast-moving consumer goods (FMCG) sector bellwether reported disappointing earnings on Friday. The commentary by a couple of brokerages was uninspiring for investors with CITI reiterating an ‘Equal Weight’ rating, while Nuvama … Read more